Hims & Hers Health, Inc. (HIMS)
After hours:
| Previous close | 12.27 |
| Open | 12.36 |
| Bid | 12.44 x 3000 |
| Ask | 12.90 x 3100 |
| Day's range | 12.31 - 12.75 |
| 52-week range | 5.65 - 17.16 |
| Volume | |
| Avg. volume | 5,076,214 |
| Market cap | 2.678B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Yahoo Finance Video
Jefferies downgrades Hims & Hers Health on growth concerns
Jefferies has downgraded Hims & Hers Health (HIMS) to Hold from Buy, lowering its price target to $15. The analysts behind the call say expectations have now caught up to reality, limiting potential upside for the company’s numbers. Julie Hyman and Josh Lipton break down the details, questioning whether there are other categories where Hims & Hers would benefit from virtual subscribing, beyond hair loss and erectile dysfunction. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This article was written by Gabriel Roy.
- Yahoo Finance Video
Nvidia's valuation forecasts aren't 'justified': Portfolio manager
Catalyst Funds Co-Founder, CIO, and Senior Portfolio Manager David Miller joins Yahoo Finance's Julie Hyman for another installment of Good Buy or Goodbye, believing there to be risk surrounding chip giant Nvidia's (NVDA) — whose latest earnings results in February bolstered markets and tech trades — valuation trajectory. "There's no question that their company is doing incredibly well, and they're going to continue to do well in the near future," Miller states. "The question is will that continue indefinitely? Historically, you've always had boom and bust cycles in semiconductors, chipmakers. It's getting price now like that's over." On the other hand, Miller cites telehealth company Hims & Hers Health (HIMS) as his Good Buy pick, finding it to be a new solution to several problems traditional pharmacy customers still deal with. Catch more of Good Buy or Goodbye here, or watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.
- Yahoo Finance Video
Hims & Hers Health, Unity Software: After-Hours Movers
Hims & Hers Health (HIMS) shares jump in Monday's after-hours trading after sharing it achieved a profitable fourth quarter in 2023. Unity Software (U) shares sink upon posting wider than expected losses. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.
